Почетна › Колоректални карцином › Вирџинија › Arlington
Kliničke studije za Колоректални карцином u gradu Arlington, VA
54 studija za Колоректални карцином traži učesnike na lokacijama u gradu Arlington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- NEXT Virginia, Fairfax · 11 ми удаљено
A KRAS Inhibitor in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- NEXT, Fairfax · 11 ми удаљено
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- NEXT Texas LLC - Virginia, Fairfax · 11 ми удаљено
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Inova Fair Oaks Hospital, Fairfax · 11 ми удаљено
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Тражи се учесникФаза 1/2
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Clinical Study Site, Fairfax · 11 ми удаљено
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 ми удаљено
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · 11 ми удаљено
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Arlington
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- NEXT Virginia, LLC, Fairfax · 11 ми удаљено
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · 11 ми удаљено
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Fairfax · 11 ми удаљено
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Тражи се учесникФаза 2/3
- Local Institution - 0278, Fairfax · 11 ми удаљено
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- Inova Schar Cancer, Fairfax · 11 ми удаљено
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Trial Site, Fairfax · 11 ми удаљено
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Тражи се учесникФаза 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 ми удаљено
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists, PC, Reston · 14 ми удаљено
- и још 1
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Тражи се учесникФаза 1
- ALX Center 2, Fairfax · 11 ми удаљено
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Тражи се учесникФаза 1/2
- NEXT Oncology, Fairfax · 11 ми удаљено
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Тражи се учесникФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 ми удаљено
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT - Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Next Virginia, Fairfax · 11 ми удаљено
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Тражи се учесникФаза 1/2
- Next Oncology Virginia, Fairfax · 11 ми удаљено
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Тражи се учесникФаза 1/2
- NEXT, Virginia, Fairfax · 11 ми удаљено
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Studije za Колоректални карцином u drugim gradovima
- Houston, TX101 студија
- New York City, NY86 студија
- Nashville, TN67 студија
- Boston, MA62 студија
- Los Angeles, CA61 студија
- St. Louis, MO51 студија
- San Antonio, TX43 студија
- Philadelphia, PA41 студија
- Grand Rapids, MI40 студија
- Baldwin Park, CA37 студија
- Tampa, FL36 студија
- Seattle, WA35 студија
Ostale studije u gradu Arlington
- Немалоклетни карцином плућа111 студија
- Метастатски карцином52 студија
- Рак (све врсте)52 студија
- Рак дојке50 студија
- Рак јајника47 студија
- Рак плућа42 студија
- Карцином ендометријума41 студија
- Рак панкреаса33 студија
- Плоскоклеточни карцином главе и врата29 студија
- Sitnoćelijski rak pluća22 студија
- Trostruko negativni rak dojke21 студија
- Рак желуца21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.